{
  "id": 1768146310850,
  "seqId": 73,
  "title": "Microbial Keratitis: Clinical Assessment & Management",
  "summary": "A comprehensive guide to microbial keratitis, a common sight-threatening ophthalmic emergency. This poster outlines assessment protocols, microbiological processing, intensive sterilization phases, and advanced surgical interventions for corneal perforations.",
  "date": "2026-01-11T15:45:10.850Z",
  "data": {
    "title": "Microbial Keratitis: Clinical Assessment & Management",
    "summary": "A comprehensive guide to microbial keratitis, a common sight-threatening ophthalmic emergency. This poster outlines assessment protocols, microbiological processing, intensive sterilization phases, and advanced surgical interventions for corneal perforations.",
    "summary_illustration": "<svg viewBox=\"0 0 100 100\" xmlns=\"http://www.w3.org/2000/svg\"><circle cx=\"50\" cy=\"50\" r=\"40\" fill=\"none\" stroke=\"hsl(215, 90%, 45%)\" stroke-width=\"2\"/><path d=\"M20 50 Q50 10 80 50 Q50 90 20 50\" fill=\"none\" stroke=\"hsl(215, 90%, 45%)\" stroke-width=\"2\"/><circle cx=\"50\" cy=\"50\" r=\"8\" fill=\"hsl(215, 90%, 75%)\" opacity=\"0.6\"/><path d=\"M45 45 L55 55 M55 45 L45 55\" stroke=\"hsl(0, 70%, 50%)\" stroke-width=\"1.5\"/></svg>",
    "sections": [
      {
        "title": "Introduction & Critical Pitfalls",
        "icon": "report_problem",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "red",
        "content": "Microbial keratitis is a common sight-threatening, mostly treatable, ophthalmic emergency. Common pitfalls include delay in diagnosis, inappropriate sample collection, injudicious or inadequate therapy, drug toxicity, and delayed follow-up, all of which may result in suboptimal visual outcome."
      },
      {
        "title": "Table 7.5: Risk Factors for Microbial Keratitis",
        "icon": "groups",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Category",
            "Type",
            "Specific Factors"
          ],
          "rows": [
            [
              "Ocular",
              "Trauma",
              "Corneal abrasion"
            ],
            [
              "Ocular",
              "Contact Lens (CL)",
              "Extended wear > soft > daily disposable > rigid gas-permeable (RgP); poor hygiene"
            ],
            [
              "Ocular",
              "Iatrogenic",
              "Corneal surgery (e.g. LASIK); Removal of suture; Loose suture; Topical immunosuppression to the eye or around the eye (eg guttae corticosteroids or ciclosporin, facial tacrolimus, inhaled corticosteroids); Long-term topical antibiotics"
            ],
            [
              "Ocular",
              "Surface Disease",
              "Dry eyes; Bullous keratopathy; Immune-mediated ocular surface disease; Progressive conjunctival scarring disorders; Chronic blepharokeratoconjunctivitis; Chronic keratitis (e.g. HSV); Neurotrophic keratitis (e.g. HSV, VZV, tumours of the cerebellopontine angle)"
            ],
            [
              "Ocular",
              "Lid Disease",
              "Entropion; Lagophthalmos; Trichiasis"
            ],
            [
              "Ocular",
              "Nasolacrimal",
              "Chronic dacryocystitis"
            ],
            [
              "Systemic",
              "Immunosuppression / Nutritional",
              "Drugs; Immunodeficiency syndromes; Diabetes; RA; Vitamin A deficiency"
            ]
          ]
        }
      },
      {
        "title": "Clinical Features & Presentation",
        "icon": "visibility",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "Pain, FB sensation, redness, photophobia, tearing, discharge (may be purulent), dVA.",
          "Circumlimbal/diffuse injection.",
          "Single or multiple foci of white opacity within stroma ± oedema.",
          "Usually associated epithelial defect and anterior uveitis.",
          "NB: May present insidiously as infectious crystalline keratopathy (see E Deposition keratopathies, p. 302)."
        ]
      },
      {
        "title": "Complications",
        "icon": "warning",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Limbal and scleral extension",
          "Corneal perforation",
          "Endophthalmitis (rare unless perforation or organisms like gonococcus or fungi that penetrate intact epithelia)",
          "Panophthalmitis"
        ]
      },
      {
        "title": "Investigations: Protocol",
        "icon": "biotech",
        "type": "process",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Perform early and adequate corneal scrapes.",
          "If CL wearer: Send lenses, solutions, and cases for culture (warn patient they will be destroyed).",
          "Liaise with microbiologists regarding incubation length, sensitivities, and unusual features.",
          "Take a swab for molecular diagnostics (PCR) if herpetic disease is a suspected underlying risk factor."
        ]
      },
      {
        "title": "Box 7.1: How to Perform a Corneal Scrape",
        "icon": "colorize",
        "type": "process",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Instil preservative-free topical anaesthesia (perform scrape prior to use of fluorescein).",
          "Use a Kimura spatula, No. 15 blade, or 25g needle.",
          "Scrape both the base and leading edge of the ulcer (from uninvolved to involved cornea).",
          "Place material onto glass slide for microscopy and staining (gram stain, Ziehl–Neelsen, methenamine silver, etc.).",
          "Plate onto blood agar (aerobes), chocolate agar (Neisseria, Haemophilus), and Sabouraud agar (fungi).",
          "Consider non-nutrient Escherichia coli-enriched agar (if Acanthamoeba suspected).",
          "When plating small samples, rows of ‘C streaks’ aid dilution of inoculum and identification of individual spp.",
          "Use separate needles for each agar dish.",
          "Consider culture in thioglycollate (anaerobes) and enrichment (bacteria) broths."
        ]
      },
      {
        "title": "Table 7.6: Microbiological Processing",
        "icon": "science",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Media/Stain",
            "Target Organism (B: Bacteria, F: Fungi, A: Acanthamoeba, M: Mycobacteria, N: Nocardia)"
          ],
          "rows": [
            [
              "Gram stain",
              "B, F, A"
            ],
            [
              "Giemsa stain",
              "B, F, A"
            ],
            [
              "Gomori/methenamine silver",
              "F, A"
            ],
            [
              "Periodic acid–Schiff (PAS)",
              "F"
            ],
            [
              "Calcofluor white",
              "F, A"
            ],
            [
              "Ziehl–Neelsen",
              "F, A, M, N"
            ],
            [
              "Blood agar / Chocolate agar",
              "B"
            ],
            [
              "Sabouraud dextrose agar",
              "F"
            ],
            [
              "Thioglycollate broth",
              "B(an) - Anaerobic bacteria"
            ],
            [
              "Non-nutrient E. coli-enriched agar",
              "A (Acanthamoeba)"
            ],
            [
              "Lowenstein–Jensen",
              "M (Mycobacteria)"
            ]
          ]
        }
      },
      {
        "title": "Treatment Strategy: Sterilization & Healing",
        "icon": "medical_services",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "Sterilization Phase: Appropriate topical antibiotics administered intensively for 48–72h.",
          "Healing Phase: Topical corticosteroids added with lubricants (reduce shear forces); reduced antibiotic frequency."
        ]
      },
      {
        "title": "Initial Treatment Actions",
        "icon": "first_aid",
        "type": "process",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Stop CL wear. Report CL-related keratitis to MHRA using yellow card system.",
          "Admit patient if severe infection or poor compliance (see Box 7.2).",
          "Intensive topical antibiotics: Hourly empirical broad-spectrum (one or two antibiotics).",
          "Combined therapy (e.g., cefuroxime + ofloxacin) + non-preserved if OSD or immunocompromised.",
          "Consider oral Ciprofloxacin (750mg 2x/d) for limbal lesions or perforation.",
          "Cycloplegia (e.g. cyclopentolate 1% 2x/d) and oral analgesia.",
          "Oral Tetracyclines & Vitamin C for stromal necrosis (inhibit MMPs/cytokines)."
        ]
      },
      {
        "title": "Box 7.2: Indications for Admission",
        "icon": "hotel",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Severe infection: >1.5mm-diameter infiltrate",
          "Central corneal ulcer",
          "Hypopyon, purulent exudate, or complicated disease",
          "Poor compliance likely: Administering drops or daily review",
          "Other concern: ‘Only eye’, failing to improve, etc."
        ]
      },
      {
        "title": "Box 7.3: Empirical Therapy Options",
        "icon": "medication",
        "type": "mindmap",
        "layout": "half_width",
        "color_theme": "blue",
        "content": {
          "center": "Empirical Treatment",
          "branches": [
            "Combined Therapy: Fortified Cephalosporin (Cefuroxime 5%) + Fluoroquinolone (Ofloxacin). Penicillin 0.3% if Strep suspected.",
            "Caution: Aminoglycosides (Gentamicin 1.5%) cause toxicity/necrosis (especially in OSD).",
            "Monotherapy: Fluoroquinolones (Ofloxacin, Levofloxacin, Moxifloxacin) adequate for most but not resistant Staph aureus/Pseudomonas.",
            "Preference: Always use non-preserved therapy in OSD patients."
          ]
        }
      },
      {
        "title": "Table 7.7: Common Bacterial Causes",
        "icon": "bug_report",
        "type": "table",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "headers": [
            "Organism",
            "Frequency",
            "Penetration Intact Epithelium",
            "Virulence"
          ],
          "rows": [
            [
              "Staphylococcus aureus (Gram +ve)",
              "Common",
              "-",
              "+"
            ],
            [
              "Staphylococcus epidermidis (Gram +ve)",
              "Common",
              "-",
              "±"
            ],
            [
              "Streptococcus pneumoniae (Gram +ve)",
              "Common",
              "-",
              "++"
            ],
            [
              "Haemophilus (Gram -ve)",
              "Common in children",
              "+",
              "+"
            ],
            [
              "Pseudomonas aeruginosa (Gram -ve)",
              "Common in CL wearers",
              "-",
              "+++"
            ],
            [
              "Neisseria gonorrhoeae (Gram -ve)",
              "Common in neonates",
              "+",
              "+++"
            ]
          ]
        }
      },
      {
        "title": "Ongoing Management & Monitoring",
        "icon": "monitoring",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "green",
        "content": [
          "Daily review: inflammation, epithelial defect size (slit-lamp), infiltrate/hypopyon size, oedema, anterior uveitis.",
          "Taper frequency and switch to non-fortified preparations with clinical improvement.",
          "Add lubricants and introduce topical steroids (e.g. dexamethasone 0.1%, prednisolone 0.5%) carefully following re-epithelialization/sterile culture.",
          "If no growth and clinically ineffective: Withhold treatment for 12h, then reserape or biopsy.",
          "Restain original slides to identify less common organisms (mycobacteria, fungi)."
        ]
      },
      {
        "title": "Management of Complications",
        "icon": "healing",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Persistent Epithelial Defect (>2wk): Switch to non-preserved, reduce drop frequency, add lubricants, assist lid closure (tarsorrhaphy).",
          "Resistant/Progressive Keratitis: Seek specialist advice. Scleral extension: Oral Ciprofloxacin. Matrix remodelling: Doxycycline 50mg OD and Vitamin C 1g BD.",
          "Threatened Perforation: Oral Cipro, therapeutic CL, glue, or emergency PK (usually after 2d intensive treatment).",
          "Endophthalmitis: Diagnostic vitrectomy and intravitreal antibiotics."
        ]
      },
      {
        "title": "Corneal Perforation Treatments",
        "icon": "construction",
        "type": "mindmap",
        "layout": "half_width",
        "color_theme": "purple",
        "content": {
          "center": "Perforation Options",
          "branches": [
            "Therapeutic CL: For microperforations/no tissue loss. High-water content; acts as mechanical scaffold for epithelial sliding.",
            "Tissue Adhesives: <2mm perforations. Enbucrilate (cyanoacrylate) + 4mm polythene patch + hydrogel CL. Avoid aminoglycosides. Repeated use is toxic.",
            "Amniotic Membrane: Larger perforations. Layered AM constructs + fibrin sealant (fibrinogen/aprotinin + thrombin/CaCl2) ± sutures.",
            "Surgical Reconstruction: Lamellar/Full-thickness keratoplasty ± AM overlay ± therapeutic CL ± immunosuppression."
          ]
        }
      }
    ]
  },
  "chapterId": "cornea"
}